

![]() |
The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents |
|
Authors | ||
Published in | International Journal of Cardiology. 2013, vol. 168, no. 2, p. 1466-71 | |
Abstract | We aimed to assess the cost effectiveness of the sirolimus-eluting stent (SES) in diabetic and non-diabetic patients vs. bare metal stents (BMS). | |
Keywords | Aged — Cohort Studies — Cost-Benefit Analysis/methods/trends — Drug-Eluting Stents/economics/trends — Female — Follow-Up Studies — Humans — Male — Metals/economics — Middle Aged — Myocardial Revascularization/economics/trends — Registries — Risk Factors — Stents/economics/trends | |
Identifiers | PMID: 23336951 | |
Full text | ||
Structures | ||
Research group | Epidémiologie clinique (115) | |
Citation (ISO format) | BARONE-ROCHETTE, Gilles et al. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents. In: International Journal of Cardiology, 2013, vol. 168, n° 2, p. 1466-71. doi: 10.1016/j.ijcard.2012.12.054 https://archive-ouverte.unige.ch/unige:42490 |